Thread: Redefining PD
View Single Post
Old 02-15-2007, 05:57 AM
paula_w paula_w is offline
In Remembrance
 
Join Date: Aug 2006
Location: Florida
Posts: 3,904
15 yr Member
paula_w paula_w is offline
In Remembrance
 
Join Date: Aug 2006
Location: Florida
Posts: 3,904
15 yr Member
Default Redefining PD

Olsen posted this in another thread; Jaye spoke of Langston in another thread too. I'm adding forum notes to this theory.

Neurosci Lett. 2007 Jan 14; [Epub ahead of print] Related Articles, Links

Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.

Ferrer I, Perez E, Dalfo E, Barrachina M.

Institut de Neuropatologia, Servei Anatomia Patologica, IDIBELL-Hospital Universitari de Bellvitge, Facultad de Medicina, Universitat de Barcelona, Hospitalet de Llobregat, Spain.

Prohibitin and ATP synthase protein levels were examined in the substantia nigra and frontal cortex (area 8) in five cases of Parkinson's disease (PD), five cases of dementia with Lewy bodies pure form (pDLB), five cases of early Alzheimer's disease (AD stage IIA, B), nine cases with advanced AD (stages V/VIC), and nine controls. A significant reduction of prohibitin and ATP synthase was observed in the substantia nigra in PD cases. In contrast, increased prohibitin and ATP synthase levels were found in the frontal cortex in PD, and increased prohibitin but not ATP synthase in the frontal cortex in pDLB. Superoxide dismutase 2 (SOD2) expression levels were also increased in the frontal cortex in PD and pDLB. No modifications in prohibitin and ATP synthase levels were found in the frontal cortex in sporadic AD. These findings demonstrate disease-specific modifications in the expression of mitochondrial-related proteins in the frontal cortex at stages of PD in which there is no alpha-synuclein aggregation in the form of Lewy bodies and Lewy neurites in this area. These findings emphasize the presence of mitochondrial modifications before the appearance of histological hallmarks of PD, and point to the possibility of a more extended molecular pathology in PD than currently accepted.

PMID: 17284347 [PubMed - as supplied by publisher]

==============

The forum talk given by Dr. Bill Langston, the guy who realized that a synthetic forum of heroin could be used as a PD model in animals, thus enabling research, clarified some things that have been talked about as precursors of PD as actually the early stages if the disease itself, thus eliminating the substantia nigra as being the point of origin. He speculates that it could begin in the brain stem, [this slide included a picture of the Vagus nerve], the gut, and other places. He thinks it then [from the substantia nigra] moves on to the cortex. [I don't have a handout and we heard this speaker over lunch so those with the handout chime in here].

Thus, loss of smell and constipation in a PD patient are actually the disease itself in early stages because they are symptoms, not precursors. By the time you get to motor symptoms, it could be too late and much further down the line than the beginning of the illness. He bases his theory on the presence of Lewy bodies, which are clumps containing the protein alpha synuclein. He said the normal person has two expressions of nuclein and a PD patient has double that. Lewy bodies do not only appear in the brains of PD patients in autopsy, but also in the gut and several other areas. Therefore over expression of nuclein is a major factor.

There is more and I don't remember it all so will stop here. We do not know the purpose of normal nuclein expression. Whoever discovers that, will possibly hit a jackpot.

Langston even suggested possibly changing the name of the illness itself, offered perhaps the name Parkinson Lewy Disease, as he feels that Lewy's work is as significant and that a much expanded definition of the illness is needed.

Other highlights: Duopdopa trial coming to the U.S. this summer rather than the originally reported January of this year. The lady from Europe who spoke wasn't sure if it was phase II or phase III because she "doesn't understand the FDA." This treatment holds much promise for evening out symptoms.

A provocative new theory involving calcium channels was presented but I have to check notes on that before posting.

Interesting fact: James Parkinson, after whom the illness was named, thought the illness was caused by stress.
__________________
paula

"Time is not neutral for those who have pd or for those who will get it."
paula_w is offline   Reply With QuoteReply With Quote